Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease ...
In the relatively few U.S. cases of human bird flu so far recorded, symptoms have typically been mild -- congestion, pink eye ...
As the ‘miracle’ drugs sweep the globe, pubs, bars and drinks manufacturers are scrambling to cope with an unexpected side ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
(Reuters) -Cigarette maker Philip Morris International on Thursday forecast 2025 profit above estimates after recording ...
On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...